Online Consultation For Penile Cancer Treatment Doctors in Herzliya

Dr. Eyal Fenig is a specialized Surgical Oncologist in Israel. And one of the most sought after medical specialists in Herzliya, Israel. The doctor has over 15 Years of experience and is associated with Herzliya Medical Center.

Association and Memberships Dr. Eyal Fenig is part of:

• American Society for Radiotherapy and Oncology
• Israeli Association of Oncologists

Qualifications :

• MD from the Faculty of Medicine at the Technion in Haifa
• Specialization in Oncology held in Beilinson Hospital
• Internships and narrow specialization in the field of radiotherapy in Sloan Kettering Medical Center, New York, USA (Memorial Sloan Ketering Cancer Center)

Hospital Address :

Herzliya Medical Center, Ramat Yam Street, Herzliya, Israel

What is the medical expertise of Dr Eyal Fenig?

• Dr Eyal Fenig has 15 years of experience as a surgical oncologist. He is skilled in providing effective treatments for prostate cancer and lymphoma. Dr Fenig performs procedures like stereotactic radiotherapy and intensity-modulated radiotherapy on a regular basis.
• Dr Fenig is a member of noteworthy organizations such as the Israeli Association of Oncologists and the American Society for Radiotherapy and Oncology.
• He completed a minor specialization in Radiotherapy at the Sloan Kettering Medical Center in New York, USA. Dr Fenig finished a Fellowship at the Radiation Oncology Department at the Memorial Sloan Kettering Cancer Center in New York.
• Over the course of his career, Dr Fenig has published several papers in respected scientific journals. Some of these include:
  1. Maloof P, Wang Q, Wang H, Stein D, Denny TN, Yahalom J, Fenig E, Wieder R. Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat. 1999 Jul;56(2):153-67.
  2. Sidi Y, Panet C, Cyjon A, Fenig E, Beery E, Nordenberg J. Guanosine potentiates the antiproliferative effect of cytosine-beta-D-arabinofuranoside in melanoma cell lines. Cancer Invest. 1993;11(5):523-9.
  3. Fenig E, Lurie H, Sulkes A. The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol. 1993 Feb;16(1):54-7.